A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Clinical trial NCT07221357 · RECRUITING

Trial details

NCT number: NCT07221357
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Untreated, Unresectable, or Metastatic Colorectal Cancer

Start date: 2025-12-31
Primary completion: 2030-02-02
Enrollment: 990

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.